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Abstract
Exhaustion is a dysfunctional state of cytotoxic CD8+ T cells (CTL) observed in chronic
infection and cancer. Current in vivo models of CTL exhaustion using chronic viral infections
or cancer yield very few exhausted CTL, limiting the analysis that can be done on these
cells. Establishing an in vitro system that rapidly induces CTL exhaustion would therefore
greatly facilitate the study of this phenotype, identify the truly exhaustion-associated
changes and allow the testing of novel approaches to reverse or prevent exhaustion. Here
we show that repeat stimulation of purified TCR transgenic OT-I CTL with their specific pep-
tide induces all the functional (reduced cytokine production and polyfunctionality, decreased
in vivo expansion capacity) and phenotypic (increased inhibitory receptors expression and
transcription factor changes) characteristics of exhaustion. Importantly, in vitro exhausted
cells shared the transcriptomic characteristics of the gold standard of exhaustion, CTL from
LCMV cl13 infections. Gene expression of both in vitro and in vivo exhausted CTL was dis-
tinct from T cell anergy. Using this system, we show that Tcf7 promoter DNA methylation
contributes to TCF1 downregulation in exhausted CTL. Thus this novel in vitro system can
be used to identify genes and signaling pathways involved in exhaustion and will facilitate
the screening of reagents that prevent/reverse CTL exhaustion.
Author summary
In this manuscript, we describe an in vitro method that rapidly establishes large numbers
of exhausted CD8+ T cells. The exhaustion of CTL induced by this method has been fully
validated by multiple approaches (cytokine production, polyfunctionality, cytotoxicity,
in vivo proliferation, inhibitory receptors, transcription factors, RNAseq and DNA
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methylation). This method will facilitate not only the study of T cell exhaustion but also
the screening of drugs. As proof of point, we use this method to show that TCF-1 downre-
gulation in terminally exhausted T cells is accompanied by Tcf7 DNA promoter methyla-
tion and show that a transmethylase inhibitor can prevent TCF-1 downregulation. Our
method presents a critical resource for the study of CTL exhaustion and the screening of
drugs and interventions.
Introduction
Cytotoxic CD8+ T cells (CTL) play a critical role in eliminating viral infection and controlling
cancer development. During chronic viral infection and cancer, CTL acquire a state of dys-
function that is often referred as CTL exhaustion which was originally described in chronic
Lymphocytic Choriomeningitis Virus (LCMV) infection of mice [1]. CTL exhaustion has been
documented in humans in chronic viral infections such as human immunodeficiency virus
(HIV), hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and in most human
cancers [2–9] and is thought to be a central mechanism behind the failure of CTL to eliminate
chronically infected and cancerous cells. Preventing and/or reverting exhaustion therefore
constitutes a promising approach to restore the function of these CD8+ T cells. This requires
however an in depth understanding of the mechanisms that lead to exhaustion and the stimuli
that affect exhausted CD8+ T cells.
In recent years, the characteristics of exhausted CTL have been intensively researched by
comparing antigen-specific CTL in chronic viral infection or cancer with effector and memory
cells in acute virus infection [10–12]. Exhaustion is characterized by loss of cytokine produc-
tion, such as interleukin-2 (IL-2), tumor necrosis factor-α (TNF-α) and interferon-γ (IFN-γ),
decreased cytokine polyfunctionality, diminished expansion potential [13] and sustained high
expression of multiple inhibitory receptors such as PD-1, Tim3, Lag3, TIGIT, CD160 and
CD244 [14–17].
The phenotypic and functional changes of exhausted CTL arise from an altered transcrip-
tional profile and modified epigenetic landscape [12, 18–20]. Altered expression of transcrip-
tion factors and repressors such as T cell factor-1 (TCF) [21, 22], Thymocyte selection-
associated HMG box protein (TOX) [23–27], T-box transcription factor 21 (T-bet) [12],
Eomesodermin (EOMES) [1], IRF4 [28], NR4a [29] and BAFT [30] are indicative for the
exhaustion phenotype. For example, transcription factor T-bet and TCF1 commonly expressed
by functional effector and memory CTL, are also expressed by exhausted CTL, but are associ-
ated with distinct gene expression [12, 31, 32]. TOX expression has been associated with
molecular and epigenetic programs of CTL exhaustion [23, 24, 26, 27]. In addition, in compar-
ison to effector and memory CTL, exhausted CTL also have a distinct epigenetic landscape
that contributes to their phenotypic changes and gene expression [19, 20].
To study T cell exhaustion, in vivo mouse models are commonly used where T cell exhaus-
tion is either induced through chronic viral infection or cancer. LCMV infection is a well-char-
acterized mouse model for CD8+ T cell exhaustion [10, 33]. The exhausted phenotype is also
detected among tumor infiltrating lymphocytes (TIL) in tumor mouse models [34, 35]. The
persistence of the antigen has been shown to be the crucial element [36] and chronic antigen
stimulation alone is sufficient to induce CTL exhaustion in vivo [37, 38]. Previous in vitro
exhaustion protocols have failed to validate T cell exhaustion, assuming inhibitory receptor
expression and reduction of IL-2 production as surrogates for dysfunction [39]. Some of these
changes, however, such as expression of PD-1 and CD160 also accompanies T cell activation
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while loss of IL-2 production is a feature of effector differentiation. Thus a fully validated in
vitro exhaustion system has yet to be established.
The importance of CTL exhaustion in chronic infections and cancer demands rapid in vitro
methods to screen new approaches that can prevent or revert CTL exhaustion. Inducing CTL
exhaustion in vivo is time-consuming, requiring more than 30 days and yields limited numbers
of exhausted cells as experimental material. Most importantly the in vivo milieu in these mod-
els is characterized by inflammation, high viral loads, suppressive cytokines or cells; all of
which can obscure the phenotype of exhausted CTL and therefore make it hard to dissect true
exhaustion-associated changes. Our newly developed in vitro method circumvents all of the
above mentioned issues and allows gene manipulation and screening of small molecules or
antibodies that could restore the function of exhausted CTL and/or prevent the induction of
exhaustion. Using this system, we can show that the Tcf7 promotor is methylated in exhausted
CTL and using DNA transmethylase inhibitors one can prevent the downregulation of TCF1.
Therefore, this 5-day in vitro exhaustion system enables the rapid testing of new approaches to
prevent and/or revert exhaustion in T cells and therefore may facilitate the development of
new therapies for chronic infections and cancer.
Results
Repeat stimulation with cognate peptide to induce CTL exhaustion
Because of the critical role sustained antigen stimulation plays in driving CD8+ T cells to exhaus-
tion [36], we utilized repeat peptide stimulations of OVA(257–264)−specific TCR transgenic OT-I
cells to induce CTL exhaustion in vitro. To induce exhaustion, CD8+ T cells purified from OT-I
mice were stimulated daily for five days with 10ng/ml OVA(257–264) peptide in the presence of IL-
15 and IL-7 (Repeat peptide stimulation, Fig 1A). As controls, cells were either left unstimulated
or stimulated only once with OVA(257–264) peptide for 48 hours and then washed and cultured
without peptide for an additional 3 days. All cells were cultured with IL-7 and IL-15. On day 5,
cells were either harvested for analysis or in some instances cells were cultured an additional 3
days in the presence of IL-7 and IL-15 without any additional peptide stimulation (Fig 1A).
An important feature of this in vitro exhaustion system is that it rapidly yields large num-
bers of exhausted cells within 5 days (Fig 1B). Single peptide stimulations yielded comparable
numbers while unstimulated culture numbers remained largely unchanged. The expansion in
the numbers of exhausted T cells represents a ~9-fold increase from the T cell numbers seeded.
Thus this in vitro exhaustion system can yield large numbers of exhausted CTL that can be
used to further study and manipulate the pathways that drive exhaustion.
Repeat peptide stimulation reduces cytokine production and leads to loss
of polyfunctionality
Since hierarchical loss in the capacity to produce cytokines is one of the most critical charac-
teristics of exhausted CD8+ T cells [10], we first examined the capacity for cytokine release
upon peptide re-stimulation. After five days of culture, the cells were harvested and stimulated
with OVA(257–264) peptide in the presence of Golgi plug for 6 hours. More than 40 percent of
the unstimulated cells could produce IFN-γ upon re-stimulation (46±4%, mean ± standard
error, Fig 1A and 1B). Single peptide stimulated cells were also able to produce IFN-γ (58±4
%). In contrast, repeat peptide stimulated cells had impaired IFN-γ production with only 27±
3% of cells able to produce IFN-γ after re-stimulation (Fig 2A and 2B). In addition, very few
repeat peptide stimulated cells (4.8±0.4%) could produce TNF-α compared to single peptide
stimulated cells (44±4%) and unstimulated cells (71±4%) (Fig 2A and 2B). IL-2-producing
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Fig 1. Scheme of the experimental protocol and numbers of live exhausted CTL generated by in vitro exhaustion. (A) Scheme of the experimental set up.
IR: Inhibitory receptors, TF: Transcription factors, IC: Intracellular. (B) Purified CD8+ T cells (0.5x106 cells per well) were cultured either unstimulated,
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cells could barely be detected in the repeat peptide stimulated cells after re-stimulation, while
IL-2 was readily produced by single peptide stimulated cells (37±3%) and unstimulated cells
(60±4%) (Fig 2A and 2B). Ultimately, these results demonstrate that repeat peptide stimulation
of CD8+ T cells in vitro leads to impaired cytokine production in a manner that has been pre-
viously reported in exhausted CD8+ T cells, first IL-2 production is lost followed by TNF-α
and finally IFN-γ.
Exhausted CD8+ T cells, unlike memory cells, cannot produce multiple cytokines at the
same time, and we therefore assessed the polyfunctionality of our in vitro generated cells. For
this, the percentage of single, double and triple cytokine producing cells were determined and
visualized using the SPICE software. In unstimulated cultured cells, 33% produce all three
cytokines simultaneously upon peptide stimulation while significant percentages of these cells
were double producer (Fig 2C). Only 15% of the cells did not produce any of these three cyto-
kines. Similarly, in the single peptide stimulated cells, 18% were triple positive for all three
cytokines, large numbers were double cytokine producers, while 26% were incapable of releas-
ing any of these cytokines (Fig 2C). In contrast, 70% of the repeat peptide stimulated cells
could not produce any cytokines after re-stimulation. IFN-γ single producers were 25% of the
cells, while very few cells produced other cytokines (Fig 2C). To demonstrate the persistence of
the cytokine profile of repeat peptide stimulated cells, we rested cells without peptide for
another 3 days before examining their cytokine production. We found that the reduced cyto-
kine production of repeat peptide stimulated cells was maintained after resting (S1A Fig).
Degranulation is an important step for the CD8+ T cell cytotoxicity. We therefore analyzed
the degranulation marker CD107a and Granzyme B (GzmB) expression in our cells. When
cells were analyzed without peptide re-stimulation, cells either unstimulated or single peptide
stimulated were negative for CD107a and GzmB (Fig 3A and 3B), while repeat peptide stimu-
lated cells showed a significantly higher level of both markers (Fig 3A and 3B). When cells
were re-stimulated with OVA(257–264) peptide, cells cultivated in the presence of no peptide
and single peptide stimulated cells upregulated CD107a (Fig 3A). In contrast, repeat peptide
stimulated cells failed to increase CD107a expression after re-stimulation, indicating that these
cells are not able to degranulate further upon re-stimulation. Granzyme B was increased in
repeat peptide stimulated cells in agreement with the terminal differentiation of exhausted
cells (Fig 3B). No increase of GzmB was detected after 6 hours of re-stimulation for any of the
conditions analyzed (Fig 3B). Repeat peptide stimulated cells exhibited reduced cytotoxic
capacity against OVA(257–264) peptide-loaded tumor cells (Fig 3C). These findings clearly show
that after repeat stimulation in vitro, CTL lose their ability to make cytokines, have reduced
polyfunctionality, cannot degranulate further, have increased GzmB and reduced cytotoxicity.
All of these features are characteristics of the dysfunctional state of in vivo exhausted CTL.
Multiple inhibitory receptors were upregulated following repeat peptide
stimulation
An increase in inhibitory receptor expression corresponds to a more exhausted state [17]. After
harvesting on day five, the cells were stained immediately for the surface expression of the inhibi-
tory receptors PD-1 (CD279), CD244, CD160, Lag3 (CD223), Tim-3 (CD366) and TIGIT. As
expected, inhibitory receptors were barely expressed on the cells without peptide stimulation and
single peptide stimulated cells (Fig 4A and 4B), except for PD-1, where 20±4% of the single
stimulated once with peptide and repeat peptide stimulated. Live cells were counted on day 5. Pooled data showing absolute cell numbers (left) and fold
expansion (right). Data are from n = 13 and 10 independent experiments.
https://doi.org/10.1371/journal.ppat.1008555.g001
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Fig 2. Repeat peptide stimulated CD8+ T cells show reduced cytokine production capacity and lose polyfunctionality. Purified OT-I CD8+ T cells were cultured
either without peptide (no peptide), stimulated one time for 2 days with OVA peptide (single peptide) or stimulated with OVA peptide daily (repeat peptide). On day 5
cells were harvested and re-stimulated with OVA peptide. (A) Representative flow cytometry plots showing frequency of cytokine producing live CD8+ T cells after re-
stimulation. (B) Pooled data showing the frequency of cytokine producing cells after re-stimulating with OVA peptide. (C) SPICE figures depicting the frequency of cells
producing one, two or three cytokines in different combinations. Each symbol represents one animal (n = 11–12), 9 independent experiments performed. Line depicts
mean ± SE. Between the groups, Student’s t test with Welch’s correction was performed except for % IFN-γ+ (ANOVA with Tukey’s post hoc test). �<0.05, ��P<0.01,
���P<0.001, ����P<0.0001.
https://doi.org/10.1371/journal.ppat.1008555.g002
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peptide stimulated cells expressed this inhibitory receptor. In contrast, there was a significant
upregulation of multiple inhibitory receptors on repeat peptide stimulated cells. Almost all of
these cells became PD-1 positive (98±0.3%, Fig 4A and 4B). Furthermore, 74±5% and 76±4% of
the cells, respectively, express TIGIT and Lag3. The expression of Tim3 (64±2%), CD160 (58±4%)
and CD244 (14±2%) was also significantly increased on the repeat peptide stimulated cells.
We next examined the simultaneous co-expression of multiple inhibitory receptors (PD-1,
Lag3, CD160 and CD244) using SPICE (Fig 4C). Repeat peptide stimulated cells were 39%
double positive for the inhibitory receptors and another 39% of the cells co-expressed three of
these inhibitory receptors simultaneously. Furthermore, 11% of the cells expressed all 4 inhibi-
tory receptors (Fig 4C). In contrast, very few of the no peptide and single peptide stimulated
cells expressed two or more inhibitory receptors (Fig 4C). The differences in inhibitory recep-
tor expression remained even after resting repeat peptide stimulated cells for 3 days (S1B Fig).
To exclude that differences in inhibitory receptor expression were due to a different activa-
tion status, all the cells were re-stimulated for 6 hours after harvesting them on day 5. Although
reactivation induces a slight upregulation of some inhibitory receptors on the no peptide and
single peptide cultures, they still remain much lower than the repeat peptide stimulated cul-
tures (S2A Fig). The exception was CD160 which was upregulated to similar levels in all cells.
Overall, these findings confirm that multiple inhibitory receptors are expressed on the repeat
peptide stimulated cells.
Expression of transcription factors is altered in repeat peptide stimulated cells
Previous studies have reported that exhausted CTL express and utilize transcription factors
(TF) differently compared to effector and memory cell [11, 12, 40]. To characterize the expres-
sion pattern of TF in the in vitro exhausted cells, four of the core TFs (TCF1, TOX, T-bet, and
Fig 3. Repeat peptide stimulated CD8+ T cells have decreased cytotoxic function. On day 5, cells were harvested and re-stimulated with OVA peptide. (A) Median
fluorescence intensity (MFI) of the degranulation marker, CD107a, shown (left panel). Fold change of CD107a MFI induced by peptide re-stimulation depicted on the
right panel. (B) MFI of Granzyme B (GzmB) depicted for the different culture conditions. Each symbol represents one animal (n = 11–12), 9 independent experiments
performed. (C) No peptide, single peptide and repeat peptide stimulated cells were co-culture with target cells (OVA-pulsed AE-17 cells) at different ratios. Percentage of
specific killing is depicted. One of five independent experiments shown. Line depicts mean ± SE. Between the groups, Student’s t test with Welch’s correction was
performed except for CD107a MFI (Wilcoxon signed rank test). �<0.05, ��P<0.01, ���P<0.001, ����P<0.0001.
https://doi.org/10.1371/journal.ppat.1008555.g003
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EOMES) were measured. TCF1 has been reported to play a critical role in identifying subsets
of exhausted T cells [22, 41]. Early exhausted or the progenitor exhausted cells maintained
TCF1 expression, while terminally exhausted T cells downregulate its expression. In compari-
son to single peptide stimulation, repeat peptide stimulation induced down-regulation of
TCF1 expression and upregulation of GzmB (Fig 5A and 5B). TOX expression was reported to
be increased on exhausted cells [2, 23–25, 40], and indeed we also found TOX to be signifi-
cantly upregulated in the repeat peptide stimulated cells in comparison to unstimulated and
single peptide stimulated cells (Fig 5A and 5B). These differences in TOX and TCF1 expression
persisted even after resting 5 day cultures for another 3 days (S1C and S1D Fig) but also after
reactivation of cells (S2B and S2C Fig). T-bet and EOMES expression in exhausted CD8+ T
cells were dependent on the stage of exhaustion [1, 42]. Although in vitro single peptide stimu-
lation already increased the expression of T-bet, repeat peptide stimulation further signifi-
cantly upregulated T-bet (Fig 5A and 5C). Around 90% of the repeat peptide stimulated cells
were T-bet+/PD-1+ double positive whereas in single peptide simulated cells T-bet+ cells were
mostly PD-1 negative (S2D and S2E Fig). In vitro peptide stimulation downregulated EOMES,
with no detectable difference of EOMES expression comparing repeat with the single peptide
stimulated cells (Fig 5A and 5C). The increased TOX and T-bet accompanied by decreased
TCF-1 expression in repeat peptide stimulated CTL is in agreement with the TF profile of in
vivo exhausted CTL [25, 41, 42].
Repeat peptide stimulated cells have decreased in vivo expansion capacity
To evaluate the in vivo expansion capacity of repeat peptide stimulated cells, we sorted live
CD8+ T cells from in vitro cultures (no peptide, single peptide and repeat peptide stimulated
cells) and adoptively transferred 104 live CD45.1+ CD8+ T cells into wild type CD45.2+ mice
that were infected 3h later with WSN-OVA influenza virus. Freshly isolated naïve CD8+ T
cells from an OT-I spleen were also transferred as controls. At day 10 post infection, mice were
harvested and the number of donor CD45.1+ cells in the lung were measured. We found a sig-
nificant reduction in the frequency (23% versus 68% and 66%, for repeat peptide, single pep-
tide and no peptide, respectively, Fig 6A) as well as absolute cell numbers (3.2x106, 11.8x106
and 12.6x106, for repeat peptide, single peptide and no peptide respectively, Fig 6B) for the
repeat peptide stimulated cells compared to all controls. Freshly isolated naïve cells did not dif-
fer from cells of single and no peptide cultures. The numbers of repeat peptide stimulated
donor cells were also reduced in mediastinal lymph nodes (MLN) and spleens (S3 Fig). This
indicated that repeat peptide stimulated cells are less capable of expanding after being exposed
to their specific antigen. Meanwhile, the mice that received the repeat peptide stimulated cells
possessed a larger frequency and number of endogenous CD45.2+ OVA(257–264)-specific CTL
in their lungs than mice that received unstimulated or single peptide stimulated cells (fre-
quency: 4.5% versus 0.8% and 1.1%, Fig 6C; cell numbers: 0.6x106 versus 0.1x106 and 0.2x106,
for repeat peptide, single peptide and no peptide respectively, Fig 6D). This indicates that the
adoptively transferred repeat peptide stimulated cells were less efficient than the other donor
cells to compete with the endogenous antigen-specific CTL response. These results indicated
Fig 4. Repeat peptide stimulated cells express multiple inhibitory receptors. The expression of the inhibitor receptors PD-1, CD244, CD160, Lag3 were determined
by flow cytometry on day 5 of in vitro culture of OT-I CD8+ T cells. Cells were cultured either without peptide (no peptide), one time OVA peptide stimulation (single)
or daily peptide stimulations (repeat peptide). (A) Representative flow cytometry plots depicting the frequency of live CD8+ T cells expressing inhibitory receptors. (B)
Pooled data of frequency of CTL expressing individual inhibitory receptors within the different culture conditions. (C) SPICE figures depicting the frequency of CD8
+ T cells expressing one, two, three or four inhibitor receptors (PD-1, CD244, CD160, Lag3) simultaneously. Each symbol representative one animal (n = 7–11), with
7–9 independent experiments performed. Line depicts mean ± SE. Between the groups, Wilcoxon signed rank test was performed with exception of % Tim-3+ and %
CD160+ for which a Student’s t test with Welch’s correction was used. �<0.05, ��P<0.01, ���P<0.001, ����P<0.0001.
https://doi.org/10.1371/journal.ppat.1008555.g004
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that in vitro repeat peptide stimulation resulted in a reduced capacity of CTL to expand when
re-exposed to their cognate antigen. This further supports our notion that in vitro repeated
antigen stimulation results in exhaustion of these cells.
Repeat peptide stimulated cells have the transcriptional profile of
exhausted CTLs
To determine whether repeat peptide stimulated cells also have a distinct transcriptional pro-
file, we performed RNAseq on sorted live CD8+ T cells from the different culture conditions.
Fig 5. Repeat peptide stimulation induces a distinct pattern of transcription factor expression. Transcription factors (TF) were analyzed in OT-I CD8+ T cells on day
5 of culture. Cells either unstimulated (no peptide), stimulated one time (single peptide) or daily (repeat peptide) shown. (A) Representative flow cytometry plots of the
frequency of TF-expressing live CD8+ T cells shown for the differently treated cultures. (B) Pooled data depicting the MFI of TCF1 and TOX in live CD8+ T cells. (C)
Pooled data showing the frequency of EOMES and T-bet expressing live CD8+ T cells. Each symbol represents one animal (n = 9–12), with n = 7–9 independent
experiments performed. Line depicts mean ± SE. ANOVA with Tukey’s post hoc test was performed on TCF1 MFI, Student’s t test with Welch’s correction was used for
TOX MFI and Wilcoxon signed rank test for data in (C). �<0.05, ��P<0.01, ���P<0.001, ����P<0.0001.
https://doi.org/10.1371/journal.ppat.1008555.g005
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As shown in the principle component analysis (PCA) (Fig 7A), the samples clustered together
and where distinctly separated depending upon their in vitro treatment. We identified 1196
genes with more than 2-fold increased expression and 1218 genes with more than 2-fold
downregulation in the repeat peptide stimulated cells relative to that in single peptide stimu-
lated cells. The transcriptional prolife of the repeat peptide stimulated cells is clearly more dis-
tinct than those of the single and non-stimulated cells (Fig 7B and S1 Table). Among the
upregulated genes, multiple inhibitory receptor encoding genes, including PD-1 (Pdcd1),
Lag3, Tim3 (Havcr2), CD160, Tigit and CTLA4 were presented on the top of this list. As
expected, the genes for the markers of the terminal differentiated effector cells, like GzmB,
GzmC and Prf1 were also significantly upregulated on the repeat peptide stimulated cells (Fig
7C). The transcription factors, Eomes and Tcf7 were downregulated by 4.0 and 6.6 fold, respec-
tively, while Tox was found to be 2.9 fold increased in the repeat peptide stimulated cells com-
pared to single peptide stimulated cells (Fig 7C), confirming our flow cytometry findings of
these TFs (Fig 5B and 5C). Furthermore, TFs, which are associated with CTL exhaustion such
as IRF4 [28], NR4a [29] and Batf [30] were also upregulated in the repeat peptide stimulated
cells in comparison to single peptide and no peptide stimulated cells (Fig 7C).
To assess whether differentially expressed genes in repeat peptide stimulated cells were
enriched for genes that characterize in vivo exhausted CTL from LCMV cl13 infections, we
Fig 6. Repeat peptide stimulation decreases in vivo CTL expansion capacity. OT-I CD8+ T cells were cultured without peptide stimulation (no peptide), one-
time stimulation (single peptide) or daily stimulation (repeat peptide) and sorted on day 5. Live CD8+ T cells were adoptively transferred into wild type mice
which were then infected with the OVA(257–264)-expressing influenza virus WSN-OVA. Freshly isolated OT-I CD8+ T cells from a naïve mouse were also
transferred (naïve OT-I). Lungs were harvested on day 10 post infection. (A) Frequency of donor CD45.1+ OT-I CD8+ T cells within total lung CD8+ T cells
shown. (B) Absolute number of lung donor CD45.1+ OT-I CD8+ T cells depicted. (C) Frequency of endogenous CD45.2+ OVA-specific CD8+ T cells within the
total lung CD8+ T cells shown. (D) Absolute number of endogenous CD45.2+ OVA-specific CD8+ T cells shown. Each symbol represents one animal (n = 8–9)
from n = 3 independent experiments. Line depicts mean ± SE. To determine significant differences between the different animal groups, a Mann-Whitney U test
was used except for data in (A) (ANOVA with Tukey’s post hoc test). ���P<0.001, ����P<0.0001.
https://doi.org/10.1371/journal.ppat.1008555.g006
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performed gene set enrichment analysis (GSEA). Differentially expressed genes between repeat
peptide stimulated cell and single peptide stimulated cells were compared to public gene sets
of upregulated or downregulated in in vivo exhausted CTLs (gene set GSE87646). Gene sets
upregulated in exhaustion were found to be significantly more enriched in the repeat peptide
stimulated upregulated genes compared to single peptide stimulated cells (Fig 7D). Conversely,
the gene sets that were reported to be downregulated in exhausted cells were more enriched in
the genes that were downregulated in repeat peptide stimulated cells versus the single peptide
stimulated cells (Fig 7D). Thus, GSEA demonstrated significant transcriptional similarity
between in vitro repeat peptide stimulated cells and in vivo exhausted cells. To further investi-
gate signaling pathways that distinguish repeat peptide stimulated cells from single peptide
stimulated cells, we performed IPA analysis. The most significant pathway with upregulated
activity in repeat peptide stimulated cells was the T cell exhaustion signaling pathway (Fig 7E).
The above findings clearly show that in vitro repeat peptide stimulation results in the transcrip-
tional changes of in vivo exhausted CD8+ T cells from LCMV cl 13 infections which serve as
the benchmark of CTL exhaustion.
Repeat peptide stimulation results in hyper-methylation of the Tcf7
transcriptional regulatory region
Changes in methylation of transcription regulatory region have been described in exhausted
CTLs [18, 43]. In order to identify whether in vitro repeat peptide stimulated cells also possess
similar epigenetic characteristics of exhausted CTLs, whole genome methylated DNA sequenc-
ing (MeD-seq) [44] was performed on the sorted live CD8+ T cells. Stimulated T cells undergo
distinct genome wide DNA methylation changes depending on the type of treatment (Fig 8A
and S2 Table). In comparison to unstimulated and single peptide stimulated cells, the tran-
scriptional regulatory region of Pdcd1 had significantly less DNA methylation in the repeat
peptide stimulated cells (Fig 8B, left). When comparing the promotor methylation status (2kb
region surrounding the TSS) of Tcf7, there was more DNA methylation detected in repeat pep-
tide stimulated than in the single peptide stimulated cells or unstimulated cells (Fig 8B, center).
Meanwhile, in the promotor region of the GzmB, significantly less DNA methylation was
found in the repeat peptide stimulated cells than in the other cells (Fig 8B, right), which was in
line with the higher expression of the protein upregulated in the repeat peptide stimulated cells
(Fig 3B). Besides Pdcd1, none of the other inhibitory receptor genes’ regulatory or promotor
regions were found to possess significant differences in methylation status, although some of
them showed expected trends in DNA methylation changes at their TSS. Interestingly, the
DNA methylation states of the cytokine genes IL-2, IFN-γ and TNF-α were not significantly
different. This indicated that other gene expression control mechanisms, like histone modifi-
cations or transcription factor abundance, might regulate the differential expression of these
Fig 7. Repeat peptide stimulated cells have distinct transcriptional profile. RNAseq analysis was performed on live CD8+ T cells sorted from 5
day culture of OT-I CD8+ T cells. Cells were either without peptide (no peptide), one-time stimulation (single peptide) or daily peptide
stimulations (repeat peptide). (A) PCA plot of RNA-seq data show that cells from identical culture conditions cluster together and away from each
other. (B) Heatmap shown for the top 50 differentially expressed genes within CTL from the different culture conditions. (C) Heatmaps for the
individual genes clustered based on function presented. (D) Repeat peptide stimulated CTL transcriptomes were enriched in gene signatures of
LCMV-Cl13 exhausted CTL. Differentially expressed genes in repeat peptide stimulated CTL were analyzed by GSEA for their enrichment in gene
sets found in exhausted CTL from LCMV-Cl13 infected mice. Enrichment in upregulated (left) and downregulated (right) genes shown. (E)
Ingenuity pathway analysis was performed on the differentially expressed genes in repeat peptide stimulated cells (compared to single peptide).
Significantly upregulated pathways (orange) and downregulated pathways (blue) in repeat peptide stimulated cells are depicted. P values
(hypergeometric test) are presented as -log10.
https://doi.org/10.1371/journal.ppat.1008555.g007
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cytokines. Overall, these findings indicate that the repeat peptide stimulated cells have distinct
DNA methylation patterns and reveal that the downregulation of TCF1 expression is accom-
panied by increased promotor methylation of Tcf7.
Fig 8. Genome wide DNA methylation changes during T cell stimulation reveal Tcf7 promotor methylation. Sorted live CD8+ T cells were processed and whole
genome methylated DNA sequencing (MeD-seq) was performed. (A) Hierarchical clustering on DMRs (differentially methylated regions) found between the three
different peptide exposure conditions are shown. (B) Boxplot of DNA methylation read count data in a 2kb window surrounding the TSS of mentioned genes are shown.
The samples were collected from three independent experiments. (C) Representative histogram of TCF1 expression (left) and pooled data showing TCF1 MFI on live CD8
cells (right) in the presence or absence of 20μM DNMT inhibitor during the last 3 days of repeat peptide stimulated cells shown. Data are from n = 6 performed in 3
independent experiments, paired Student’s t test performed. ��P<0.01.
https://doi.org/10.1371/journal.ppat.1008555.g008
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To further confirm that DNA promotor methylation contributes to the downregulation of
TCF1 expression in exhausted cells we treated cells with a DNMT inhibitor for the last 3 days
of culture and examined whether TCF1 expression was modified in the repeat peptide stimula-
tion cultures. Indeed, treatment of these cells with DNMT inhibitor resulted in an increase in
TCF1 levels in exhausted CTL (Fig 8C). This further supports that DNA methylation plays a
role in silencing TCF1 as exhausted cells progress from “progenitor exhausted” to the “termi-
nally exhausted” subpopulation.
DNMT inhibitor also reduced the expression of PD-1 and Tim3 in repeat peptide stimu-
lated cells (S4 Fig). Because PD-1 and Tim3 expression are controlled by promoter region
DNA methylation [43, 45], our findings suggest that DNMT inhibitor prevented exhaustion
rather than reverted the exhaustion of T cells. These experiments suggest that the in vitro
exhaustion system we describe can be used to test reagents that modulate T cell exhaustion.
Anergy is not a feature of in vitro and in vivo exhausted CTL
The high purity of T cells in our culture system raises the question whether the absence of
CD28 costimulation induces anergy [46–48] and this explains some of the phenotypes we
observe. However, this is unlikely as our cells are cultured in the presence of IL-7 that has been
suggested to prevent anergy [49] and furthermore we still see exhaustion when cells are cul-
tured with IL-2 (S5A and S5B Fig) another anergy preventing cytokine [50, 51]. Some CD28
costimulation, however, may be present in our culture system, as repeat peptide stimulated
cells express CD80 mRNA levels 74-fold and 13-fold higher compared to unstimulated and
single peptide stimulated cultures, respectively. Flow cytometry confirmed the high surface
expression of CD80 on repeat peptide stimulated cells (S5C Fig).
To further exclude that our repeat peptide stimulated cells have features of anergy, we per-
formed GSEA for sets of genes identified by in vitro anergy induction (gene set GSE5960) [46].
We find that both genes that are upregulated and downregulated in anergic T cells, are
enriched in our repeat peptide stimulated cells (S6A and S6B Fig). Thus there is no evidence
for the presence of anergy. We found a similar enrichment for genes both upregulated and
downregulated in anergic T cells in in vivo exhausted gp33-specific CTL from LCMV clone 13
infected mice (gene set GSE41867) [12] (S6C and S6D Fig).
Finally, we performed pathway enrichment analysis by IPA on the genes differentially
expressed between repeat peptide stimulated cells and the unstimulated cells. We found that
anergy related signaling pathway was neither up- or down-regulated in the repeat peptide
stimulated cells (S6E Fig). In this comparison, the T cell exhaustion signaling pathway was
again the most significant upregulated pathway. Taken together, these findings argue that
anergy is not a major feature of our in vitro exhausted CTL.
Discussion
Persistent antigen stimulation is a key driver of T cell exhaustion [37, 38]. In this study, we
show that repeat stimulation with peptide is sufficient to induce T cell exhaustion in vitro.
Repeat peptide stimulation rapidly, within 5 days, induced all characteristics of CTL exhaus-
tion including loss of cytokine production and polyfunctionality, the expression of multiple
inhibitory receptors, reduced expansion capacity and competitive fitness, transcription factor
and gene expression patterns all compatible with in vivo generated exhausted CTL [10, 11].
This phenotype was largely preserved when cells were rested for several days. Our in vitro
repeat peptide stimulation culture conditions include cytokines IL-7 and IL-15 which are
known to have anti-apoptotic potential and ensure T cells do not undergo activation induced
cell death (AICD) [52]. In particular, IL-15 has been shown to promote the survival of
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exhausted HIV-specific CD8+ T cells by upregulating Bcl-2 and Bcl-xL [7, 53]. Its inclusion in
the repeat peptide stimulations, we argue, promotes the survival of these cells as they become
gradually more exhausted while avoiding the increased apoptosis mediated by IL-2, a known
promotor of T cell AICD [54].
The in vitro exhausted CTL we generate have many of the molecular features of exhaustion.
In particular transcription factors that associate and orchestrate T cell exhaustion are clearly
modulated in the same manner as seen with in vivo induced CTL exhaustion of chronic infec-
tion models like LCMV clone 13 infections and cancer [11, 31]. The transcription factor TOX
is known to be increased in in vivo exhausted CTL [23, 24, 26], while TCF-1 is downregulated
in exhausted cells and its presence is associated with precursor exhausted CTL that retain
some proliferative capacity [11, 40]. All in vitro exhausted CTL we generate have high protein
expression for TOX and Tox mRNA is upregulated by 2.6-fold. Furthermore, in vitro
exhausted CTL have downregulated TCF-1 and at the mRNA level its gene Tcf7 is decreased
by 6.6-fold. A recent report indicated that Prdm1 and c-maf transcription factors control a co-
inhibitory module in T cells [55]. Although we found that Prdm1 expression was upregulated
by 4.5-fold in our in vitro exhausted CTL, we did not find any changes in c-maf transcription
factor. Activated protein C receptor (PROCR) and podoplanin (PDPN), recently reported to
be co-inhibitory receptors [55], were not upregulated in our in vitro exhausted cells. This may
not be surprising as these markers were only found in tumor infiltrating T cells and IL-27 may
be mediating this profile [55]. Exhausted T cells from chronic infection however are not
affected by IL-27 signaling [56] and thus PROCR and PDPN expression may depend on the
tumor microenvironment and not characterize all exhausted CTL. Our in vitro exhaustion
method generates exhausted T cells which may more closely reflect the core features of exhaus-
tion. Our method is independent of environmental factors that may occur in the in vivo setting
of chronic infection or tumor microenvironment. Such factors can obscure direct exhaustion
related transcriptional changes from those induced by bystander effects such as high viral
loads.
Our in vitro exhaustion method utilizes peptide-stimulated purified CD8+ T cells and
therefore one could question whether TCR stimulation in the absence of costimulation induces
anergy in our T cells. Although, T cell anergy and exhaustion may share some traits and poten-
tial signaling pathways of unresponsiveness to restimulation, the mechanisms of their induc-
tion is very different. Analyzing gene expression and signaling pathways we found no evidence
for anergy in our in vitro exhausted CTL. Similar data were obtained with in vivo exhausted
CTL. The reason we do not induce anergy in our cultures is because they are carried out in the
presence of IL-7 and IL-15. It is well established that γc chain cytokines such as IL-2 and possi-
bly IL-7 and IL-15 can override the induction of anergy when CD8+ T cells are stimulated in
the absence of CD28 costimulation [47, 49–51]. Cells were exhausted even when cultured with
IL-2, albeit IL-2 in these cultures increases cell death significantly. Interestingly, our in vitro
exhausted CTL express high levels of mRNA and surface CD80 and this may also contribute to
preventing anergy. This is not surprising as activated mouse T cells can express CD80 both in
vitro but also in vivo in autoimmune mice [57, 58]. Thus in vitro exhausted CTL do not present
key anergy traits although one cannot exclude that some downstream signaling or inhibitory
pathways are shared between exhaustion and anergy.
Previous studies have reported that there are subsets of exhausted CTLs, one known as
“progenitor exhausted” cells which express TCF1 and TOX, corresponding to cells that retain
the capacity to expand with checkpoint blockade therapy and the other subpopulation known
as the “terminally exhausted” cells which are TCF1 low and cannot respond to checkpoint
blockade [26, 40, 41, 59]. In our in vitro exhausted cell cultures, we observed both subsets; a
subset of cells that express low levels of TCF1 and high levels of TOX and GzmB, which is in
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line with the characteristics of “terminally exhausted” T cells and a subset that is TCF1+TOX
+ corresponding to the “progenitor exhausted” cells. All cells are T-bethi PD1+, thus our TOX
+ cells may retain some “progenitor exhausted” characteristics as T-bethi cells are reported to
retain proliferative capacity in the exhaustion setting [42]. Thus, these two subsets exist in our
exhausted cultures and this allows us to perform future in depth characterization of these cells
and establish their relationship and the factors that control them. CXCR5+ T cells were
described as “less exhausted” and responders to check-point blockade in chronic viral infec-
tion [21, 59]. Although “progenitor exhausted” TCF1+TOX+ are present in our repeat peptide
stimulated T cells, we could not detect any CXCR5 expression. CXCR5+ exhausted CD8+ T
cells are found in lymphoid organs but not in peripheral blood or other infected organs of
LCMVclone13 infected animals [21], and therefore our CXCR5- in vitro exhausted cells may
resemble more the later than those found in lymphoid organs.
TCF1 downregulation in exhausted cells was reported to be accompanied by reduced chro-
matin accessibility [24, 25]. Our findings suggest that DNA methylation also contributes to
reduced TCF1 expression as both the Tcf7 promotor was found to be hyper-methylated and
the inhibition of DNA methyltransferases during the last 3 days of culture results in the reten-
tion of TCF1 expression in our exhausted CTL. Whether these TCF1 high cells generated by
DNMT inhibitor treatment retain all the characteristics of the “progenitor exhausted” cell sub-
set remains to be determined. If true it may indicate that such inhibitors can be combined with
checkpoint inhibition therapy as such TCF1+ cells are the major responders to therapy.
By studying these in vitro exhausted CTLs, the accumulation of inhibitory receptor expres-
sion on exhausted cells can be better understood. PD-1, Tim-3 and TIGIT are rapidly
expressed on the early exhausted cells, while the other receptors, like CD160 and CD244, were
induced more slowly by repeat antigen stimulation. Because of the promising effects of the
checkpoint blockade therapy, such as anti-PD1/PD-L1, on the treatment of human cancer
[60], there is considerable interest to revive the function of exhausted T cells by co-blockade of
multiple inhibitory receptors simultaneously. Our in vitro method, which induces multiple
inhibitory receptors in just a few days, can serve as a feasible tool to test blocking approaches
before performing in vivo animal experiments. For example, TIGIT blockade can be tested,
because these cells not only upregulated TIGIT, but also downregulated its competitor of the
same ligand, CD266, on their surface. Moreover, the underlying mechanisms of checkpoint
blockade on reversal of T cell exhaustion need to be further investigated as do the pathways
that restrain these cells from developing into terminally exhausted cells. Clearly the balance of
these exhausted cells can be modulated with large effects on the numbers and potentially the
function of these cells. As we recently have demonstrated, by overexpressing a single miRNA,
namely miR-155, we can ameliorate the attrition of virus-specific CTL during chronic infec-
tion and in vivo increase their numbers by 2 logs [61]. Our in vitro system of T cell exhaustion
can be used to screen the overexpression of genes with retroviruses or their inhibition or dele-
tion using CRISPR-Cas9 to discover new targets which modulate T cell exhaustion.
The method we describe allows for the rapid, within 5 days, generation of large numbers of
fully exhausted CTL and can therefore be used for medium to high throughput screening of
compounds, reagents or gene modifications that can prevent, ameliorate, reverse or accelerate
T cell exhaustion. In particular, the extreme loss of IL-2 and TNFα production in our repeat
peptide stimulated cells allows for the first time a truly medium to high throughput approach
for drug screening since changes in IL-2 or TNFα production can be easily determined in the
supernatants.
In conclusion, we have established a rapid in vitro system of CD8+ T cell exhaustion. These
exhausted CTL exhibit all the known molecular and functional characteristics of exhaustion
yet can be induced in large numbers within 5 days as opposed to the small numbers generated
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after 30 days of chronic infection of in vivo mouse models of exhaustion. This in vitro method
can not only be used as a screening system to prevent/revert CD8+ T cell exhaustion, thereby
identifying new therapies, but also for research aiming at revealing mechanisms of CD8+ T
cell exhaustion. Using this in vitro method we show that TCF1 silencing during exhaustion is
in part controlled by DNA methylation. Overall, this in vitro method makes the future study of
CTL exhaustion more feasible and reduces the need for in vivo studies.
Materials and methods
Mice
OT-I CD45.1+ mice on the C57BL6/J background were generated by backcrossing C57BL/6
Tg (TcraTcrb)1100Mjb/J (OT-I) with B6.SJL-Ptprca Pepcb/BoyJ (CD45.1+) mice (both from
Charles River France, a registered vendor of The Jackson Laboratories C57BL/6 mice). C57BL/
6J mice and OT-I mice were housed in a certified barrier facility at Erasmus University Medi-
cal Center.
Ethics statement
Animal work was performed under Project Proposal (AVD101002015179) by the animal wel-
fare body (AWB) of the Instantie voor Dierenwelzijn (IvD). All animal experiments were con-
ducted in compliance with the Netherlands’ government laws of the Centrale Commissie
Dierproeven (CCD).
Repeated antigen stimulation in vitro
CD8+ T cells were purified from spleens of OT-I mice by negative selection with magnetic
beads (EasySep, Stemcell Technologies). After purification, cells were 97.7±0.5% CD8+ T cell
and contained 0.11±0.04% CD11b+ CD11c- monocytes and 0.09±0.05% CD11b+ CD11c
+ dendritic cells. In each well of a 24-well plate, 5x105 of the purified CD8+ T cells/ml were
cultured in complete media (RPMI 1640, 10% FBS (Gibco), 1% 2mM L-glutamine (Life Tech-
nologies), 1% HEPES (Life Technologies), 1% 100nM Sodium Pyruvate (Life Technologies),
1% non-essential amino acides (Life Technologies), 100U/ml penicillin (Gibco) and 100μg/ml
Streptomycin-sulfate (Gibco), 0.05mM Betamercaptoethanol (Sigma)) with IL-15 (5ng/ml,
Peprotech, Cat 210–15) and IL-7 (5ng/ml, Peprotech, Cat 210–07) with or without 10ng/ml
OVA(257–264) peptide (Anaspec Cat AS-60193).
For single peptide stimulation, cells were cultured in the presence of OVA(257–264) peptide
for 48 hours. The peptide was then removed by washing the cells two times with complete
media. For the remaining 3 days, the cells were cultured in the complete media with cytokines.
For repeat peptide stimulation, 10ng/ml OVA(257–264) peptide was added daily for five days.
The cells were washed also on day 2 to allow for comparable culture conditions. Unstimulated
control cells were cultured in media with cytokines but without adding peptide. Cells from all
three conditions were checked daily, and when the cells were confluent, they were split and
cultured with fresh complete media containing cytokines. After day 5, some of the cell were
washed two times with complete media and maintained in the media only with cytokines for
another three days. In some experiments cell cultures were treated on day 2 with 20μM DNA
methyltransferase (DNMT) inhibitor SGI-1027 (Tocris, Bio-techne) that targets DNA methyl-
transferases DNMT3B, DNMT3A and DNMT1.
On day five, cells were harvested and counted using an automated counting system (Count-
ess, Life Technologies). Cells were stained with DAPI Viability dye (Beckman Coulter, Cat
B30437) and Acridine Orange (Biotium, Cat 40039) to distinguish live and dead cells.
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In vitro killing assay
AE17 cells were maintained in RPMI 1640 supplemented with 10% FBS (Gibco), 100 units/mL
Penicillin/Streptomycin (Life Technologies), 2 mM L-glutamine (Life Technologies), 0.05 mM
2-mercaptoethanol (Sigma), and were cultured at 37˚C in 5% CO2. AE17 cells were pulsed
with 1 μg/ml OVA(257–264) Peptide (Anaspec Cat AS-60193) for 1 hour and then the cells were
washed thoroughly before they were labelled with the CellTrace Far Red fluorescent dye (Ther-
moFisher Scientific Cat C34564/15396613). Un-pulsed cells were not labeled. A 1:1 mix of pep-
tide pulsed and un-pulsed AE17 cells (105 each) were mixed and different amounts of T cells
(Effector: Target ratios: 3:1, 1:1, 0.3:1) were added. The cells were harvested after 16 hours, the
ratio of labeled and unlabeled tumor cell were detected by flow cytometry.
Flow cytometry
To investigate phenotypic and functional changes, cells were stained with monoclonal antibod-
ies and analyzed using flow cytometry. The following fluorochrome-conjugated monoclonal
antibody combinations against surface and intracellular antigens were used; Inhibitory recep-
tors and ligands: anti-CD8-eFluor 450 (53–6.7, eBioscience), anti-Lag3-APC (C9B7W, BD Bio-
sciences), anti-PD-1-APC-Cy7 (19F.1A12, Biolegend), anti-CD244-PE (2B4, BD Biosciences;
eBio244F4, eBioscience), anti-Tim3-PE-Cy7 (RMT3-23, Invitrogen), anti-CD160-PE-CF594
(CNX46-3, BD Biosciences), anti-TIGIT-FITC (GIGD7, eBioscience); Activation and differenti-
ation: anti-CD44-BV785 (IM7, BD Biosciences), anti-CD25-APC-Cy7 (PC61, BD Biosciences);
Cytokines and effector molecules: anti-IFN-γ-APC (XMG1.2, eBioscience), anti-TNF-α-AF488
(MP6-XT22, eBioscience), anti-IL-2-PE (JES6-5H4, eBioscience), anti-GranzymB-PE-Cy7
(NGZB, eBioscience); Intracellular expression of transcription factors anti-Tbet-PE-Cy7 (4B10,
Biolegend), anti-TCF1-APC (C63D9, Cell Signaling), anti-EOMES-PE- eFluor F610 (Dan11-
mag, eBioscience), anti-Tox-PE (TXRX10, eBioscience). To exclude apoptotic and dead cells,
Annexin V conjugated with APC, Cy5.5 or PerCP-Cy5.5 (BD Biosciences) was included in all
the stains and 2.5 mM CaCl2 was added to all solutions.
On day 5, cells were harvested and immediately stained for surface and intracellular anti-
gens. For surface staining, cells were washed with FACS wash (HBSS containing 3% FBS and
0.02% sodium azide) and incubated with 20μL mix of the pre-determined optimal concentra-
tions of the fluorochrome-conjugated monoclonal antibodies at 4˚C in the dark for 20 min-
utes. The cells were then washed once with FACS wash and fixed with 1% PFA. For the
transcription factor staining, cells were first stained for surface antigens as described above.
Following the washing step, cells were fixed with FoxP3 Fixation Buffer (005523, eBioscience)
for 60 minutes in the dark at 4˚C and then washed with Perm/Wash buffer (008333,
eBioscience) and stained with a mix of antibodies against transcription factors for 1 hour at
4˚C in the dark. Cells were then washed twice with Perm/Wash buffer and fixed with 1% PFA.
Appropriate isotype controls were included for staining of transcription factors.
To analyze cytokine production, cells were re-stimulated with the 10μg/ml OVA(257–264)
SIINFEKL peptide for 6 hours at 37˚C, 5% CO2 in the presence of GolgiPlug (BD Biosciences)
and anti-CD107a-APC-Cy7 antibodies (ID4B, Biolegend). Cells were then stained with surface
marker antibodies as described above. After washing with FACS wash, cells were fixed with IC
Fixation Buffer (88–8824, eBioscience) at 4˚C overnight, washed with Perm/Wash buffer and
stained for intracellular cytokines for 45 min in the dark at 4˚C. After staining, cells were
washed twice with Perm/Wash buffer and fixed with 1% PFA.
Cells were measured on a LSRFortessa (BD Biosciences) using application settings and at
least 200,000 events were collected. Data was then analyzed with FlowJo software (Version
9.9.4, Treestar, Ashland, OR, USA).
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In vivo influenza model
For influenza virus infection studies, live CD45.1+ OT-I cells were sorted from in vitro cultures
on a FACSAria III (BD Biosciences) using fluorochrome-conjugated Annexin V and anti-CD8
antibodies and 10,000 cells were intravenously transferred into 8–12 weeks old CD45.2
+ C57BL/6J wild-type recipient mice. Naïve CTL were also freshly isolated from spleen of an
OT-I mouse and adoptively transferred. Three hours later, mice were anesthetized with 2.5%
isoflurane gas and infected intranasally with influenza virus strain A/WSN/33-expressing
OVA (WSN-OVA, a gift from Dr. D. Topham, University of Rochester Medical Center). Body
weight was measured daily to track the influenza infection.
Ten days post infection, the lung, spleen and mediastinal lymph nodes were harvested and
single cell suspensions were obtained after processing the tissues. As described previously [62],
lungs were digested for 2 h at 37˚C with 3.0 mg/ml collagenase A and 0.15 μg/ml DNase I
(Roche) in RPMI 1640 containing 5% heat-inactivated FBS, 2 mM L-glutamine, 100 IU/ml
penicillin, 100 μg/ml streptomycin. Digested lungs were then filtered through a 40-μm cell
strainer (Falcon) and washed in the same media as above. PE-conjugated tetramers of H-2Kb
major histocompatibility complex class I loaded with OVA(257–264) were used to identified the
antigen-specific CTLs in the lungs [63].
RNA sequencing
To compare the gene expression between the different culture conditions, RNA sequencing
was performed. On day 5, 1x106 live CD8+ T cells were sorted from the three different culture
conditions and immediately lysed with TRIzol LS reagent (Life Technologies) and stored at
-80˚C. RNA was extracted according to manufacturer’s instructions and a bioanalyzer (Agi-
lent) was used to determine the integrity of the extracted RNA. Barcoded sequencing libraries
were generated using the KAPA RNA HyperPrep kit (Roche Diagnostics) with RiboErase
(HMR) rRNA depletion. Library quality was assessed with the bioanalyzer and KAPA qPCR
was performed for quantification before cluster generation and 100-bp paired-end sequencing
on a Hiseq2500 machine (Illumina). Data sets are deposited in the Gene Expression Omnibus
(GEO) database repository under accession numbers GSE150120.
Analysis of differential transcript abundance, normalization of read counts
by gene size, and downstream analyses
Four independent biological replicates were analyzed for each condition. The quality of the
sequencing was verified using the FastQC software (http://www.bioinformatics.babraham.ac.
uk/projects/fastqc/). The demultiplexed fastq files were aligned using STAR software (v.2.5.3e)
[64] with default settings and mus musculus GRCm38 as alignment reference. Then bam files,
generated during alignment, were annotated using FeatureCount software (v1.6.1) [65] to
obtain the annotated files (count files). The annotation reference was genecode.vM15.gtf.
Count data was preprocessed to remove low expressed genes. Then, rlog transformation
was applied to the clean counts for visualization and comparison purposes which include cor-
relation and clustering analysis generating the heatmaps and PCA plots during the process.
For differential expression analysis, DESeq2 (DESeq2 R package, v1.22.2) [66] was used
directly in the clean count data.
The list of differentially expressed genes was used to perform Ingenuity Pathway Analysis
(IPA, Qiagen, USA version 01–12) to further discern which pathways are involved in the CD8
+ T cell exhaustion process. Pathway enrichment P-values (Fisher’s exact test) and activation
Z-scores were calculated by IPA and used to rank the significant pathways.
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The same list of significantly differentiated genes was used for enrichment analysis (GSEA
Desktop Application, v2.2.1). The CD8+ T cell exhaustion gene-sets were downloaded from
GMO datasets (gene set GSE87646) based on the publication of Bengsch B, et al [2]). Enrich-
ment analysis in CTL exhaustion genes was determined for the upregulated and downregu-
lated genes separately. Normalized Enrichment Scores (NES) values were used to determine
whether an expression gene-set was enriched or not in CTL exhaustion genes. For anergy
GSEA analysis, gene set GSE5960 [46] and gene set GSE41867 [12] were used.
DNA methylation profiling detection
DNA methylation profiling was done as previously described by the MeD-seq method [44].
For MeD-seq sample preparation LpnPI (New England Biolabs) digestions were carried out
on DNA samples according to manufacturer’s protocol. Reactions contained 50 ng and diges-
tion took place overnight in the absence of enzyme activators. Digests of genomic DNA with
LpnPI resulted in snippets of 32 bp around the fully-methylated recognition site that contains
CpG. The DNA concentration was determined by the Quant-iT High-Sensitivity assay (Life
Technologies) and 50 ng dsDNA was prepared using the ThruPlex DNA-seq 96D kit (Takara).
Twenty microliters of amplified end product were purified on a Pippin HT system with 3%
agarose gel cassettes (Sage Science). Stem-loop adapters were blunt end ligated to repaired
input DNA and amplified (4 +10 cycles) to include dual indexed barcodes using a high fidelity
polymerase to yield an indexed Illumina NGS library. Multiplexed samples were sequenced on
Illumina HiSeq2500 systems for single read of 50 base pairs according to manufacturer’s
instructions. Dual indexed samples were demultiplexed using bcl2fastq software (Illumina).
MeD-seq data processing was carried out using specifically created scripts in Python ver-
sion 2.7.5. Raw fastq files were subjected to Illumina adaptor trimming and reads were filtered
based on LpnPI restriction site occurrence between 13–17 bp from either 5’ or 3’ end of the
read. Reads that passed the filter were mapped to mm10 using bowtie2.1.0. Multiple and
unique mapped reads were used to assign read count scores to each individual LpnPI site in
the mm10 genome. BAM files were generated using SAMtools for visualization. Gene and
CpG island annotations were downloaded from UCSC (MM10). Genome wide individual
LpnPI site scores were used to generate read count scores for the following annotated regions:
transcription start site (TSS) (1 kb before and 1 kb after), CpG islands and genebody (1 kb
after TSS till TES).
MeD-seq data analysis was carried out in Python 2.7.5. DMR detection was performed
between two datasets containing the regions of interest (TSS, genebody or CpG islands) using
the Chi-Squared test on read counts. Significance was called by either Bonferroni or FDR
using the Benjamini-Hochberg procedure. Differently methylated regions were used for unsu-
pervised hierarchical clustering, the Z-score of the read counts was used for normalization and
is also shown in the heatmaps. In addition, a genome wide sliding window was used to detect
sequentially differentially methylated LpnPI sites. Statistical significance was called between
LpnPI sites in predetermined groups using the Chi-squared test. Neighbouring significantly
called LpnPI sites were binned and reported, DMR threshold was set at a minimum of ten
LpnPI sites, a minimum size of 100 bp and either a twofold or fivefold change in read counts.
Overlap of genome wide detected DMRs was reported for TSS, CpG island and gene body
regions.
Statistical analysis
Statistical analyses were performed using Prism software (GraphPad Prism5 for Windows,
Version 5.04). The normality of data distribution was assessed using the Shapiro-Wilk
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normality test. Homogeneity of variance was tested with Bartlett’s test. When data were nor-
mally distributed and group variances were equal, an ANOVA with Tukey’s Multiple Compar-
ison Test was performed. When data were normally distributed but group variances were
unequal, a Student’s t test with Welch’s correction was performed. If data were not normally
distributed a Wilcoxon signed rank test or a Mann–Whitney U test was performed. P values
equal or lower than 0.05 were considered statistically significant with the numbers of stars in
the figures indicating the p value: � = P� 0.05, �� = P� 0.01, and ��� = P� 0.001.
Supporting information
S1 Fig. Exhaustion related features are retained after 3 days resting. Cells were harvested on
day 5, peptide was washed away and the cells were rested for 3 days without peptide. On day 8,
cytokine production after restimulation is shown (A). The expression of inhibitor receptors
(B) and transcription factors (C and D) are also shown on day 8. Each symbol represents one
animal. Line depicts mean ± SE.
(TIF)
S2 Fig. Repeat-peptide stimulated cells maintain inhibitory receptor and transcription fac-
tor differences after 6 hours of restimulation. After extra 6 hours of stimulation with OVA
peptide (10μg/ml) on day 5, the percentage and MFI of inhibitory receptors (A) and the MFI
of TCF1 (B) and TOX (C) are depicted. Representative FACS plots (D) and pooled data (E) of
the frequency of PD-1 and T-bet co-expression on day 5 shown. Line depicts mean ± SE. Each
symbol represents one animal. Data from 5–6 experiments.
(TIF)
S3 Fig. Repeat peptide stimulated cells expanded less in mediastinal lymph nodes and
spleens in vivo. OT-I CD8+ T cells were cultured without peptide stimulation (no peptide),
one-time stimulation (single peptide) or daily stimulation (repeat peptide) and sorted on day
5. Live CD8+ T cells were adoptively transferred into wild type mice which were then infected
with the Ova(257–264)-expressing influenza virus WSN-OVA. Freshly isolated OT-I CD8+ T
cells from a naïve mouse were also transferred (naïve OT-I). Mediastinal lymph nodes (MLN)
and spleens were harvested on day 10 post infection. Frequency of donor OT-I CD8+ T cells
within spleen (A) and MLN (C) in total CD8+ T cells and the absolute number of donor cells
in spleen (B) and MLN (D) are presented. Each symbol represents one animal (n = 8–9) from
n = 3 independent experiments. Line depicts mean ± SE. To determine significant differences
between the different animal groups, Mann-Whitney U test was used except for data in (A)
(ANOVA with Tukey’s post hoc test). �P<0.05, �� P<0.01, ���P<0.001, ����P<0.0001.
(TIF)
S4 Fig. DNMT inhibitor decreases expression of inhibitor receptors on the repeat peptide
stimulated cells. Pooled data showing day 5 inhibitor receptor MFI on repeat stimulated cells
in the presence or absence of 20μM DNMT inhibitor. Inhibitor was added during the last 3
days of culture. Data are from n = 6 animals, performed in 3 independent experiments. Line
depicts mean ± SE. To determine significant differences between the different treatment,
paired t-test was used �P<0.05, �� P<0.01, ���P<0.001.
(TIF)
S5 Fig. Exposure to IL-2 does not alter the exhaustion phenotypes in repeat peptide stimu-
lated cells and CD80 is upregulated on repeat stimulated cells. CD8+ T cell exhaustion was
induced in the presence of IL-2 (20U/ml) and IL-7/IL-15 (5ng/ml each). Cytokine production
after OVA peptide restimulation for 6 hours (A) and inhibitory receptor expression on day 5
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(B) are shown. n = 8 animals from 5–6 independent experiments depicted. Representative his-
togram of CD80 expression on the cells is shown in (C). One of two independent experiments
shown (n = 3).
(TIF)
S6 Fig. Anergy gene sets and pathways do not characterize repeat peptide exhausted T
cells. Both upregulated and downregulated genes in anergic T cells are enriched in exhausted
T cells. (A) GSEA of genes upregulated and (B) downregulated in anergic T cells (gene set GSE
5960) are both enriched in differentially expressed repeat peptide stimulated cells (repeat pep-
tide versus no peptide cell). (C) GSEA of genes upregulated and (D) downregulated in anergic
T cells (gene set GSE 5960) are both enriched in differentially expressed Day 30 gp33-specific
CTL from LCMV clone 13 infected animals (Day 30 versus gp33-specific CTL naïve CD8+ T
cells; data from GSE41867). (E) In repeat peptide stimulated cells the anergy related pathway
in IPA analysis was neither upregulated nor downregulated. IPA analysis was performed on
the differentially expressed genes in repeat stimulated cells (compared to no peptide). The
“Regulation of IL-2 expression in activated and anergic T lymphocytes” pathway is showed
enlarged and the overall positioning in the global IPA pathway analysis is indicated by the
arrow and red circle. Significantly upregulated pathways (orange) and downregulated path-
ways (blue), no activity pattern available (grey) are depicted. Bar graphs depict P values (hyper-
geometric test) presented as–Log10.
(TIFF)
S1 Table. Differentially expressed genes in repeat peptide stimulated T cells determined by
RNAseq. Log2 fold change is show for repeat peptide OT-I versus single peptide stimulated
OT-I. After 5 day cultures, cells were sorted and RNAseq was performed. Genes with>2 fold
change and padj value< 0.05 shown.
(PDF)
S2 Table. Differentially methylation of TSS regions was determined by MeD-seq. Fold
change is show for repeat peptide OT-I versus single peptide stimulated OT-I. After 5 day cul-
tures, cells were sorted and MeD-seq was performed. Greater than 2-fold changes shown.
(PDF)
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